静脉注射胺碘酮治疗急性心肌梗死伴持续性室速和室颤

Clinical Observation on Intravenous Amiodarone for Continuous Ventricular Tachycardia and Fibrillation in Patients with Acute Myocardial Infarction

目的：观察静脉注射胺碘酮治疗急性心肌梗死伴持续性室速和室颤的疗效。方法：对急性心肌梗死突然发作持续性室速和室颤的9例患者,在非同步电转复的同时静脉注射胺碘酮150mg,无效者10min后再重复一次,继之以0.5-1.5mg/min静点维持24-36h,同时口服胺碘酮,观察其疗效和副作用。结果：9例病人在用药的24h内持续性室速和室颤全部得到控制,1例出现一过性窦缓,无1例死亡。结论：初步观察认为静注胺碘酮治疗急性心肌梗死并持续性室速和室颤安全有效,可提高急性心肌梗死的抢救成功率。

Objective：To investigate the clinical effectiveness of amiodarone to continuous ventricular tachycardia and fibrillation in patients with acute myocardial infarction.Methods： 9 acute myocardial infarction patients with sudden continuous ventricular tachycardia and fibrillation were observed.Non-synchronous electrical cardioversion together with intravenous loading dose 150mg of amiodarone was administed,and it would be repeated once after 10min when the treatment had no effect,followed by 0.5～1.5mg/min infusion for 24～36 hours,and amidarone was given to patients orally.The curative effect and side effect were observed.Results：24hr after the administration of amiodarone in 9 patients,the continuous ventricular tachycardia and fibrillation in all of the patients were under control,temporary sinus bradycardia occurred in 1 patient,and no death occurred in all patients.Conclusion：Intravenous amiodarone is effective and safe in treating of continuous ventricular tachycardia and fibrillation in patients with AMI,also the success rate of rescue and of AMI are raised.